glp-1 leaky gut Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential Leaky Gut: Effect of Dietary

[DOI] [PubMed] [Google Scholar] 7.Lee Y.H., Lee H.W., Choi H.J

The possible mechanism affecting the development of tumors is the excessive activation or inhibition of GLP-1R expression

This technology underpins the formulation of oral semaglutide (Rybelsus) and enables its effective absorption in the stomach, as illustrated in Fig

In September 2025, the FDA reported instances of compounded GLP-1 products containing unapproved foreign substances and companies selling drugs to consumers that were falsely labeled for research purposes. A 2024 report also found that many active pharmaceutical ingredients for compounded GLP-1s were imported from unregistered foreign suppliers, raising questions about supply chain oversight